SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency
Background: Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for prolonged SARS-CoV-2 infection, but the immune defects that predispose to persistent COVID-19 remain incompletely understood. Methods: Participants enrolled in the POSt-VaccInaTIon Viral CharactEristics Study (POSITIVES), a prospective cohort study enrolling participants with confirmed SARS-CoV-2 infection. Participants were categorized based on the extent of…